Subscribe
handing-over-100-dollar-bills
21 March 2018Americas

J&J plans to sell LifeScan for $2.1bn

Johnson & Johnson (J&J) has revealed plans to sell LifeScan, its blood glucose monitoring unit, for $2.1 billion.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
J&J to acquire maker of 3D-printed spinal implants
14 September 2018   Johnson & Johnson announced this week that its subsidiary J&J Medical has acquired Emerging Implant Technologies (EIT) for an undisclosed amount.
Big Pharma
J&J to boost medical device division with acquisition
22 February 2018   Johnson & Johnson has revealed plans to strengthen its medical device capabilities with the acquisition of French medical technology company Orthotaxy.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

More on this story

Europe
J&J to acquire maker of 3D-printed spinal implants
14 September 2018   Johnson & Johnson announced this week that its subsidiary J&J Medical has acquired Emerging Implant Technologies (EIT) for an undisclosed amount.
Big Pharma
J&J to boost medical device division with acquisition
22 February 2018   Johnson & Johnson has revealed plans to strengthen its medical device capabilities with the acquisition of French medical technology company Orthotaxy.

More on this story

Europe
J&J to acquire maker of 3D-printed spinal implants
14 September 2018   Johnson & Johnson announced this week that its subsidiary J&J Medical has acquired Emerging Implant Technologies (EIT) for an undisclosed amount.
Big Pharma
J&J to boost medical device division with acquisition
22 February 2018   Johnson & Johnson has revealed plans to strengthen its medical device capabilities with the acquisition of French medical technology company Orthotaxy.

More features

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Powell Gilbert launches Düsseldorf office with leading patent litigator
Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids
Kilpatrick adds ‘seasoned litigator’ as trademark partner
WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond
Startup challenges rival over brain monitoring tech at ITC
UKIPO rejects Boehringer’s SPC for horse inhaler